Vigabatrin

Jan 27, 2020

Tuberous Sclerosis Alliance Lauds Lundbeck And FDA For Sabril Label Expansion For Patients 2 To 10 Years Old

Jan 16, 2019

FDA approves first generic version of Sabril to help treat seizures in adults and pediatric patients with epilepsy

Jul 16, 2018

Upsher-Smith Launches Vigabatrin For Oral Solution Under The Brand Name Vigadrone(TM)

May 02, 2018

Amneal Launches Generic for Sabril®: Vigabatrin for Oral Solution, USP

Dec 04, 2017

Mallinckrodt plc Presents Health Economic Data on Management of Infantile Spasms at American Epilepsy Society Annual Meeting

Aug 29, 2017

Biotechs Jump on Major Acquisitions, FDA Clearance and Clinical Trial Developments

Aug 28, 2017

Endo Begins Shipment of Generic Sabril® (vigabatrin) for Oral Solution